23
Participants
Start Date
May 31, 2001
Study Completion Date
December 31, 2003
OSI-461
Oncology & Hematology Associates of Southwest Virginia, Roanoke
Piedmont Hem Onc Assoc, P.A., Winston-Salem
Cancer Centers of the Carolinas, Greenville
Florida Oncology Associates, Jacksonville
Ocala Oncology Center, Ocala
Dayton Oncology/Hematology Consultants, Dayton
Iowa Oncology Associates, Cedar Rapids
Oncology/Hematology Associates of Kansas City, Kansas City
Tyler Cancer Center, Tyler
Hematology Oncology Associates of South Texas, San Antonio
Southwest Regional Cancer Center, Austin
Rocky Mountain Cancer Centers, Aurora
Arizona Hematology & Oncology Associates, Phoenix
Willamette Valley Cancer Center, Eugene
Cancer Care Northwest, Spokane
Lead Sponsor
Collaborators (1)
OSI Pharmaceuticals
INDUSTRY
Astellas Pharma Inc
INDUSTRY